aluates Reports

$ 0.0

Automative

Global Vaginal Fungi Infections Treatment Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-21L7452

Global Vaginal Fungi Infections Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Vaginal Fungi Infections Treatment Market Research Report 2025

Code: QYRE-Auto-21L7452

Report

July 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Bausch Health Companies Inc.

ANI Pharmaceuticals

Hikma Pharmaceuticals PLC

Lupin Ltd

Mycovia Pharmaceuticals

Glenmark Pharmaceuticals Limited

Unique Pharmaceuticals

PEPTONIC medical AB

Aurobindo Pharma Limited

Dr. Reddy’s Laboratories

Scynexis Inc

Vaginal Fungi Infections Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Vaginal Fungi Infections Treatment Market

The global market for Vaginal Fungi Infections Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Vaginal candidiasis is usually treated with antifungal medicine. For most infections, the treatment is an antifungal medicine applied inside the vagina or a single dose of fluconazole taken by mouth.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Vaginal Fungi Infections Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaginal Fungi Infections Treatment.

The Vaginal Fungi Infections Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaginal Fungi Infections Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Vaginal Fungi Infections Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Vaginal Fungi Infections Treatment Market Report

Report Metric	Details
Report Name	Vaginal Fungi Infections Treatment Market
CAGR	5%
Segment by Type	Fluconazole Nystatin Flucytosine Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, SCYNEXIS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaginal Fungi Infections Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Vaginal Fungi Infections Treatment Market report?

Ans: The main players in the Vaginal Fungi Infections Treatment Market are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, SCYNEXIS

What are the Application segmentation covered in the Vaginal Fungi Infections Treatment Market report?

Ans: The Applications covered in the Vaginal Fungi Infections Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Vaginal Fungi Infections Treatment Market report?

Ans: The Types covered in the Vaginal Fungi Infections Treatment Market report are Fluconazole, Nystatin, Flucytosine, Others

Recommended Reports

Gynecological Treatments

Antifungal Drug Markets

Infection Treatment Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Fluconazole

1.2.3 Nystatin

1.2.4 Flucytosine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Vaginal Fungi Infections Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Vaginal Fungi Infections Treatment Market Perspective (2020-2031)

2.2 Global Vaginal Fungi Infections Treatment Growth Trends by Region

2.2.1 Global Vaginal Fungi Infections Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Vaginal Fungi Infections Treatment Historic Market Size by Region (2020-2025)

2.2.3 Vaginal Fungi Infections Treatment Forecasted Market Size by Region (2026-2031)

2.3 Vaginal Fungi Infections Treatment Market Dynamics

2.3.1 Vaginal Fungi Infections Treatment Industry Trends

2.3.2 Vaginal Fungi Infections Treatment Market Drivers

2.3.3 Vaginal Fungi Infections Treatment Market Challenges

2.3.4 Vaginal Fungi Infections Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Vaginal Fungi Infections Treatment Players by Revenue

3.1.1 Global Top Vaginal Fungi Infections Treatment Players by Revenue (2020-2025)

3.1.2 Global Vaginal Fungi Infections Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Vaginal Fungi Infections Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Vaginal Fungi Infections Treatment Revenue

3.4 Global Vaginal Fungi Infections Treatment Market Concentration Ratio

3.4.1 Global Vaginal Fungi Infections Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Vaginal Fungi Infections Treatment Revenue in 2024

3.5 Global Key Players of Vaginal Fungi Infections Treatment Head office and Area Served

3.6 Global Key Players of Vaginal Fungi Infections Treatment, Product and Application

3.7 Global Key Players of Vaginal Fungi Infections Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Vaginal Fungi Infections Treatment Breakdown Data by Type

4.1 Global Vaginal Fungi Infections Treatment Historic Market Size by Type (2020-2025)

4.2 Global Vaginal Fungi Infections Treatment Forecasted Market Size by Type (2026-2031)

5 Vaginal Fungi Infections Treatment Breakdown Data by Application

5.1 Global Vaginal Fungi Infections Treatment Historic Market Size by Application (2020-2025)

5.2 Global Vaginal Fungi Infections Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Vaginal Fungi Infections Treatment Market Size (2020-2031)

6.2 North America Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Vaginal Fungi Infections Treatment Market Size by Country (2020-2025)

6.4 North America Vaginal Fungi Infections Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Vaginal Fungi Infections Treatment Market Size (2020-2031)

7.2 Europe Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Vaginal Fungi Infections Treatment Market Size by Country (2020-2025)

7.4 Europe Vaginal Fungi Infections Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Vaginal Fungi Infections Treatment Market Size (2020-2031)

8.2 Asia-Pacific Vaginal Fungi Infections Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Vaginal Fungi Infections Treatment Market Size (2020-2031)

9.2 Latin America Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Vaginal Fungi Infections Treatment Market Size by Country (2020-2025)

9.4 Latin America Vaginal Fungi Infections Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Vaginal Fungi Infections Treatment Market Size (2020-2031)

10.2 Middle East & Africa Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer Inc.

11.1.1 Pfizer Inc. Company Details

11.1.2 Pfizer Inc. Business Overview

11.1.3 Pfizer Inc. Vaginal Fungi Infections Treatment Introduction

11.1.4 Pfizer Inc. Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.1.5 Pfizer Inc. Recent Development

11.2 Bausch Health Companies Inc

11.2.1 Bausch Health Companies Inc Company Details

11.2.2 Bausch Health Companies Inc Business Overview

11.2.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Introduction

11.2.4 Bausch Health Companies Inc Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.2.5 Bausch Health Companies Inc Recent Development

11.3 ANI Pharmaceuticals

11.3.1 ANI Pharmaceuticals Company Details

11.3.2 ANI Pharmaceuticals Business Overview

11.3.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Introduction

11.3.4 ANI Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.3.5 ANI Pharmaceuticals Recent Development

11.4 Hikma Pharmaceuticals Plc

11.4.1 Hikma Pharmaceuticals Plc Company Details

11.4.2 Hikma Pharmaceuticals Plc Business Overview

11.4.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Introduction

11.4.4 Hikma Pharmaceuticals Plc Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.4.5 Hikma Pharmaceuticals Plc Recent Development

11.5 Lupin Limited

11.5.1 Lupin Limited Company Details

11.5.2 Lupin Limited Business Overview

11.5.3 Lupin Limited Vaginal Fungi Infections Treatment Introduction

11.5.4 Lupin Limited Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.5.5 Lupin Limited Recent Development

11.6 Mycovia Pharmaceuticals

11.6.1 Mycovia Pharmaceuticals Company Details

11.6.2 Mycovia Pharmaceuticals Business Overview

11.6.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Introduction

11.6.4 Mycovia Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.6.5 Mycovia Pharmaceuticals Recent Development

11.7 Glenmark Pharmaceuticals Limited

11.7.1 Glenmark Pharmaceuticals Limited Company Details

11.7.2 Glenmark Pharmaceuticals Limited Business Overview

11.7.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Introduction

11.7.4 Glenmark Pharmaceuticals Limited Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.7.5 Glenmark Pharmaceuticals Limited Recent Development

11.8 Unique Pharmaceuticals

11.8.1 Unique Pharmaceuticals Company Details

11.8.2 Unique Pharmaceuticals Business Overview

11.8.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Introduction

11.8.4 Unique Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.8.5 Unique Pharmaceuticals Recent Development

11.9 PEPTONIC medical AB

11.9.1 PEPTONIC medical AB Company Details

11.9.2 PEPTONIC medical AB Business Overview

11.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Introduction

11.9.4 PEPTONIC medical AB Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.9.5 PEPTONIC medical AB Recent Development

11.10 Aurobindo Pharma Limited

11.10.1 Aurobindo Pharma Limited Company Details

11.10.2 Aurobindo Pharma Limited Business Overview

11.10.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Introduction

11.10.4 Aurobindo Pharma Limited Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.10.5 Aurobindo Pharma Limited Recent Development

11.11 Dr. Reddy's Laboratories

11.11.1 Dr. Reddy's Laboratories Company Details

11.11.2 Dr. Reddy's Laboratories Business Overview

11.11.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Introduction

11.11.4 Dr. Reddy's Laboratories Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.11.5 Dr. Reddy's Laboratories Recent Development

11.12 SCYNEXIS

11.12.1 SCYNEXIS Company Details

11.12.2 SCYNEXIS Business Overview

11.12.3 SCYNEXIS Vaginal Fungi Infections Treatment Introduction

11.12.4 SCYNEXIS Revenue in Vaginal Fungi Infections Treatment Business (2020-2025)

11.12.5 SCYNEXIS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Bausch Health Companies Inc.

ANI Pharmaceuticals

Hikma Pharmaceuticals PLC

Lupin Ltd

Mycovia Pharmaceuticals

Glenmark Pharmaceuticals Limited

Unique Pharmaceuticals

PEPTONIC medical AB

Aurobindo Pharma Limited

Dr. Reddy’s Laboratories

Scynexis Inc

List of Tables

Table 1. Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Fluconazole

Table 3. Key Players of Nystatin

Table 4. Key Players of Flucytosine

Table 5. Key Players of Others

Table 6. Global Vaginal Fungi Infections Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Vaginal Fungi Infections Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Vaginal Fungi Infections Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Vaginal Fungi Infections Treatment Market Share by Region (2020-2025)

Table 10. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Vaginal Fungi Infections Treatment Market Share by Region (2026-2031)

Table 12. Vaginal Fungi Infections Treatment Market Trends

Table 13. Vaginal Fungi Infections Treatment Market Drivers

Table 14. Vaginal Fungi Infections Treatment Market Challenges

Table 15. Vaginal Fungi Infections Treatment Market Restraints

Table 16. Global Vaginal Fungi Infections Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Vaginal Fungi Infections Treatment Market Share by Players (2020-2025)

Table 18. Global Top Vaginal Fungi Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Fungi Infections Treatment as of 2024)

Table 19. Ranking of Global Top Vaginal Fungi Infections Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Vaginal Fungi Infections Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Vaginal Fungi Infections Treatment, Headquarters and Area Served

Table 22. Global Key Players of Vaginal Fungi Infections Treatment, Product and Application

Table 23. Global Key Players of Vaginal Fungi Infections Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Vaginal Fungi Infections Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global Vaginal Fungi Infections Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America Vaginal Fungi Infections Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Vaginal Fungi Infections Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Vaginal Fungi Infections Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Vaginal Fungi Infections Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Vaginal Fungi Infections Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Vaginal Fungi Infections Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Vaginal Fungi Infections Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Vaginal Fungi Infections Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Vaginal Fungi Infections Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Pfizer Inc. Company Details

Table 49. Pfizer Inc. Business Overview

Table 50. Pfizer Inc. Vaginal Fungi Infections Treatment Product

Table 51. Pfizer Inc. Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 52. Pfizer Inc. Recent Development

Table 53. Bausch Health Companies Inc Company Details

Table 54. Bausch Health Companies Inc Business Overview

Table 55. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product

Table 56. Bausch Health Companies Inc Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 57. Bausch Health Companies Inc Recent Development

Table 58. ANI Pharmaceuticals Company Details

Table 59. ANI Pharmaceuticals Business Overview

Table 60. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product

Table 61. ANI Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 62. ANI Pharmaceuticals Recent Development

Table 63. Hikma Pharmaceuticals Plc Company Details

Table 64. Hikma Pharmaceuticals Plc Business Overview

Table 65. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product

Table 66. Hikma Pharmaceuticals Plc Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 67. Hikma Pharmaceuticals Plc Recent Development

Table 68. Lupin Limited Company Details

Table 69. Lupin Limited Business Overview

Table 70. Lupin Limited Vaginal Fungi Infections Treatment Product

Table 71. Lupin Limited Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 72. Lupin Limited Recent Development

Table 73. Mycovia Pharmaceuticals Company Details

Table 74. Mycovia Pharmaceuticals Business Overview

Table 75. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product

Table 76. Mycovia Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 77. Mycovia Pharmaceuticals Recent Development

Table 78. Glenmark Pharmaceuticals Limited Company Details

Table 79. Glenmark Pharmaceuticals Limited Business Overview

Table 80. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product

Table 81. Glenmark Pharmaceuticals Limited Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 82. Glenmark Pharmaceuticals Limited Recent Development

Table 83. Unique Pharmaceuticals Company Details

Table 84. Unique Pharmaceuticals Business Overview

Table 85. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product

Table 86. Unique Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 87. Unique Pharmaceuticals Recent Development

Table 88. PEPTONIC medical AB Company Details

Table 89. PEPTONIC medical AB Business Overview

Table 90. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product

Table 91. PEPTONIC medical AB Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 92. PEPTONIC medical AB Recent Development

Table 93. Aurobindo Pharma Limited Company Details

Table 94. Aurobindo Pharma Limited Business Overview

Table 95. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product

Table 96. Aurobindo Pharma Limited Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 97. Aurobindo Pharma Limited Recent Development

Table 98. Dr. Reddy's Laboratories Company Details

Table 99. Dr. Reddy's Laboratories Business Overview

Table 100. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product

Table 101. Dr. Reddy's Laboratories Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 102. Dr. Reddy's Laboratories Recent Development

Table 103. SCYNEXIS Company Details

Table 104. SCYNEXIS Business Overview

Table 105. SCYNEXIS Vaginal Fungi Infections Treatment Product

Table 106. SCYNEXIS Revenue in Vaginal Fungi Infections Treatment Business (2020-2025) & (US$ Million)

Table 107. SCYNEXIS Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Vaginal Fungi Infections Treatment Picture

Figure 2. Global Vaginal Fungi Infections Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Vaginal Fungi Infections Treatment Market Share by Type: 2024 VS 2031

Figure 4. Fluconazole Features

Figure 5. Nystatin Features

Figure 6. Flucytosine Features

Figure 7. Others Features

Figure 8. Global Vaginal Fungi Infections Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Vaginal Fungi Infections Treatment Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Vaginal Fungi Infections Treatment Report Years Considered

Figure 14. Global Vaginal Fungi Infections Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Vaginal Fungi Infections Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Vaginal Fungi Infections Treatment Market Share by Region: 2024 VS 2031

Figure 17. Global Vaginal Fungi Infections Treatment Market Share by Players in 2024

Figure 18. Global Top Vaginal Fungi Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Fungi Infections Treatment as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Vaginal Fungi Infections Treatment Revenue in 2024

Figure 20. North America Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Vaginal Fungi Infections Treatment Market Share by Country (2020-2031)

Figure 22. United States Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Vaginal Fungi Infections Treatment Market Share by Country (2020-2031)

Figure 26. Germany Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Region (2020-2031)

Figure 34. China Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Vaginal Fungi Infections Treatment Market Share by Country (2020-2031)

Figure 42. Mexico Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Country (2020-2031)

Figure 46. Turkey Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Vaginal Fungi Infections Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Pfizer Inc. Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 50. Bausch Health Companies Inc Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 51. ANI Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 52. Hikma Pharmaceuticals Plc Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 53. Lupin Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 54. Mycovia Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 55. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 56. Unique Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 57. PEPTONIC medical AB Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 58. Aurobindo Pharma Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 59. Dr. Reddy's Laboratories Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 60. SCYNEXIS Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Acute Vulvovaginal Candidiasis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Candida Infections Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaginal Antifungal Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fluconazole Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Invasive Candidiasis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Topical Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fungal Keratitis Treatment Market Research Report 2024

Systemic Candidiasis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Candida Infection Testing Market Research Report 2025

Global Topical Medication for Vaginitis Market Research Report 2024

Chlamydia Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaginal Applicator Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Voriconazole for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fungal Nail Infections Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Voriconazole API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antifungal Creams Market Research Report 2025

Vaginal and Vulval Inflammatory Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diagnosing Fungal Infections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Surgical Treatment of Dermatophytosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions